<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title>Molecular Vision</journal-title><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">286</article-id><article-id pub-id-type="publisher-id">2008MOLVIS0371</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Lack of association of polymorphisms in homocysteine metabolism genes with pseudoexfoliation syndrome and glaucoma</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fan</surname><given-names>Bao Jian</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Teresa</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Grosskreutz</surname><given-names>Cynthia</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pasquale</surname><given-names>Louis</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rhee</surname><given-names>Douglas</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>DelBono</surname><given-names>Elizabeth</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Haines</surname><given-names>Jonathan L.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wiggs</surname><given-names>Janey L.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><aff id="aff1"><label>1</label>Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA</aff><aff id="aff2"><label>2</label>Center for Human Genetics Research, Vanderbilt University Medical School, Nashville TN</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to: Janey L. Wiggs, M.D., Ph.D., Associate Professor of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA, 02114; Phone: (617) 573 6440; FAX: (617) 573 6439; email: <ext-link ext-link-type="uri" xlink:href="mailto:janey_wiggs@meei.harvard.edu">janey_wiggs@meei.harvard.edu</ext-link></corresp></author-notes><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>26</day><month>12</month><year>2008</year></pub-date><volume>14</volume><fpage>2484</fpage><lpage>2491</lpage><history><date date-type="received"><day>12</day><month>11</month><year>2008</year></date><date date-type="accepted"><day>20</day><month>12</month><year>2008</year></date></history><permissions><copyright-year>2008</copyright-year><copyright-holder>Molecular Vision</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title>Purpose</title><p>To evaluate genes involved in homocysteine metabolism as secondary risk factors for pseudoexfoliation syndrome (PXFS) and the associated glaucoma (PXFG).</p></sec><sec sec-type="methods"><title>Methods</title><p>One hundred eighty-six unrelated patients with PXFS, including 140 patients with PXFG and 127 unrelated control subjects were recruited from the Massachusetts Eye and Ear Infirmary. All the patients and controls were Caucasian of European ancestry. Seventeen tag SNPs from 5 genes (methylenetetrahydrofolate reductase [<italic>MTHFR</italic>], methionine synthase [<italic>MTR</italic>], methionine synthase reductase [<italic>MTRR</italic>], methylenetetrahydrofolate dehydrogenase [<italic>MTHFD1</italic>], and cystathionine &#x003b2;-synthase [<italic>CBS</italic>]) were genotyped. Single-SNP association was analyzed using Fisher&#x02019;s exact test (unconditional) or logistic regression after conditioning on the effects of age and three <italic>LOXL1</italic> SNPs (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link>). Interaction analysis was performed between the homocysteine and <italic>LOXL1</italic> SNPs using logistic regression. Haplotype analysis and the set-based test were used to test for association of individual genes. Multiple comparisons were corrected using the Bonferroni method.</p></sec><sec><title>Results</title><p>One SNP (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=8006686">rs8006686</ext-link>) in <italic>MTHFD1</italic> showed a nominally significant association with PXFG (p=0.015, OR=2.23). None of the seventeen SNPs tested were significantly associated with PXFS or PXFG after correcting for multiple comparisons (Bonferroni corrected p&#x0003e;0.25). After controlling for the effects of age and three associated <italic>LOXL1</italic> SNPs, none of the seventeen tested SNPs were associated with PXFS (p&#x0003e;0.12). No significant interaction effects on PXFS were identified between the homocysteine and <italic>LOXL1</italic> SNPs (p&#x0003e;0.06). Haplotype analysis and the set-based test did not find significant association of individual genes with PXFS (p&#x0003e;0.23 and 0.20, respectively).</p></sec><sec><title>Conclusions</title><p>Five genes that are critical components of the homocysteine metabolism pathway were evaluated as secondary factors for PXFS and PXFG. Our results suggest that these genes are not significant risk factors for the development of these conditions.</p></sec></abstract><custom-meta-wrap><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Export to XML</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Pseudoexfoliation syndrome (PXFS) is a common condition characterized by the deposition of microfibrillar material throughout the eye. The composition of the PXFS-related material, although not completely defined, appears to be a complex glycoprotein structure containing elements of basement membranes and the elastic fiber system [<xref ref-type="bibr" rid="r1">1</xref>]. The biologic processes that cause this material to accumulate in ocular structures are not known. In eyes with PXFS, fibrillar material is found throughout the anterior segment and is typically evident on the lens capsule and in the angle where it may impede the flow of aqueous humor through the trabecular outflow pathways [<xref ref-type="bibr" rid="r2">2</xref>]. Over 50% of individuals with PXFS develop high-pressure glaucoma (PXFG) which may be associated with rapidly progressive optic nerve degeneration [<xref ref-type="bibr" rid="r3">3</xref>].</p><p>Pseudoexfoliation syndrome and the associated glaucoma appear to be genetically complex. Twin studies and reports of familial aggregation demonstrated significant heritability but not a clearly defined inheritance pattern, suggesting complex or multifactorial inheritance [<xref ref-type="bibr" rid="r4">4</xref>-<xref ref-type="bibr" rid="r6">6</xref>]. A genome-wide scan using a large Finnish family indicated potential linkage to multiple chromosome regions including 18q, 2q, 17q, and 19q [<xref ref-type="bibr" rid="r7">7</xref>]. Recently, a genome-wide association study identified significant association of three SNPs (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link>) in the lysyl oxidase-like 1 (<italic>LOXL1</italic>) gene with PXFS and PXFG in patients from Iceland and Sweden [<xref ref-type="bibr" rid="r8">8</xref>]. This association has been replicated in our study of a USA clinic-based population with broad ethnic diversity [<xref ref-type="bibr" rid="r9">9</xref>] and in other studies using ethnic populations of Caucasian [<xref ref-type="bibr" rid="r10">10</xref>-<xref ref-type="bibr" rid="r16">16</xref>], Indian [<xref ref-type="bibr" rid="r17">17</xref>], and Japanese [<xref ref-type="bibr" rid="r18">18</xref>-<xref ref-type="bibr" rid="r22">22</xref>]. These results demonstrate that <italic>LOXL1</italic> is a major gene associated with PXFS and PXFG.</p><p>Two of the highly associated <italic>LOXL1</italic> SNPs are missense changes in exon 1 (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>, G153D and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>, R141L), however, it is not yet known if these variants are biologically causative or are in linkage disequilibrium with other gene variants that are biologically active. The G153D risk allele (G) frequency is very high in PXFG patients in most of the populations studied (92%&#x02013;99%), but is also prevalent in control samples, with a frequency of over 65% in many populations [<xref ref-type="bibr" rid="r8">8</xref>-<xref ref-type="bibr" rid="r22">22</xref>]. In addition, in the Australian population the frequency of the <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> risk allele is much higher than the disease prevalence, indicating a reduction in penetrance compared to the USA and European populations [<xref ref-type="bibr" rid="r14">14</xref>]. Collectively, these results suggest that additional genetic and/or environmental factors that are potentially additive and/or protective could influence the development of this complex disorder [<xref ref-type="bibr" rid="r23">23</xref>].</p><p>Previous reports have indicated that homocysteine is moderately elevated in aqueous humor, tear fluid, and serum plasma of patients with PXFS and PXFG [<xref ref-type="bibr" rid="r24">24</xref>-<xref ref-type="bibr" rid="r26">26</xref>]. It has been proposed that mild elevations of homocysteine may contribute to the increased vascular risk that has been observed in patients with PXFS, which includes aneurysms of the abdominal aorta [<xref ref-type="bibr" rid="r27">27</xref>]. It is well recognized that hyperhomocysteinemia is associated with vascular abnormalities [<xref ref-type="bibr" rid="r28">28</xref>], and the modest elevations reported in PXFS patients could initiate vascular damage that could be further compromised by abnormal LOXL1 activity. Variants in genes that regulate the homocysteine pathways could be responsible for the observed elevations of homocysteine and these may be additive genetic factors that influence the development of the syndrome. The purpose of this study was to evaluate 5 genes encoding enzymes that regulate homocysteine metabolism as secondary factors that could contribute to PXFS and PXFG.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Patients and control subjects</title><p>One hundred eighty-six patients with PXFS were recruited from the Glaucoma Consultation Service at the Massachusetts Eye and Ear Infirmary, Boston, MA. Patients with PXFS were identified by the presence of the characteristic fibrillar material on the lens capsule or pupillary margin. Patients with iris transillumination defects without the presence of the fibrillar material were not identified as pseudoexfoliation patients, or controls. Of the 186 patients with PXFS, 140 had glaucoma (PXFG) and 46 did not (PXFNG). Glaucoma was defined as: intraocular pressure &#x0003e;22&#x000a0;mmHg in both eyes on two occasions or intraocular pressure &#x0003e;19&#x000a0;mmHg in both eyes on treatment with two or more glaucoma medications; evidence of optic nerve damage in both eyes; and visual field defects consistent with optic nerve damage and characteristic for glaucoma in at least one eye. One hundred twenty-seven control subjects were recruited from the Comprehensive Ophthalmology Service at the Massachusetts Eye and Ear Infirmary, Boston, MA. Control subjects had no evidence of pseudoexfoliation or glaucoma after clinical exam. The average age of the PXFS patients was 75. Because of the age-dependence of the pseudoexfoliation syndrome, only controls older than age 60 were used for this analysis with an average age of 72. This study population (cases and controls) included only Caucasian participants of European ancestry. Fifty-nine percent of the patients were female with 41% male, while 51% of the controls were female and 49% were male. This study adhered to the tenets of the Declaration of Helsinki and has been reviewed and approved by the Institutional Review Board of the Massachusetts Eye and Ear Infirmary. Informed consent was obtained from all patients and controls.</p></sec><sec><title>Gene polymorphisms and genotyping</title><p>Five genes that encode proteins that are involved in homocysteine metabolism were investigated in this study (<xref ref-type="fig" rid="f1">Figure 1</xref>). These genes are <italic>MTHFR</italic> (methylenetetrahydrofolate reductase), <italic>MTR</italic> (methionine synthase), <italic>MTRR</italic> (methionine synthase reductase), <italic>MTHFD1</italic> (methylenetetrahydrofolate dehydrogenase), and <italic>CBS</italic> (cystathionine &#x003b2;-synthase). Tag SNPs corresponding to linkage disequilibrium (LD) blocks were selected using <ext-link ext-link-type="uri" xlink:href="http://www.broad.mit.edu/haploview/haploview">Haploview</ext-link> (version 4.1) [<xref ref-type="bibr" rid="r29">29</xref>] according to the <ext-link ext-link-type="uri" xlink:href="http://www.hapmap.org/">HapMap</ext-link> data (release 23a) from the CEU population. The minimum minor allele frequency for checking markers was set to 0.01. Three or 4 tag SNPs were selected for each gene to capture the majority of alleles at r<sup>2</sup> greater than 0.8 across the whole gene including the 5&#x02032;UTR and 3&#x02032;UTR (<xref ref-type="table" rid="t1">Table 1</xref>). Each LD block was captured by 1 or 2 SNPs although not all alleles in each gene were captured. Genotyping was performed either by TaqMan assays (Applied Biosystems [ABI], Foster City, CA) or by direct sequencing. For the TaqMan assays, oligonucleotide primers were ordered from ABI (assay by demand) and performed according to the manufacturer&#x02019;s instructions. For direct sequencing, products from PCR amplification were purified and sequenced using BigDye<sup>&#x000ae;</sup> chemistries (ABI) and an automated genetic analyzer (model 3100; ABI). Sequence data was analyzed using <ext-link ext-link-type="uri" xlink:href="http://www.invitrogen.com/site/us/en/home/LINNEA-Online-Guides/LINNEA-Communities/Vector-NTI-Community/Vector-NTI.html">Vector NTI</ext-link> suite (version 8).</p><fig id="f1" fig-type="figure" position="float"><label>Figure 1</label><caption><p>Homocysteine metabolic pathways. Products of the enzymatic pathways are shown in rectangles, co-factors are shown in circles, and enzymes are in text. The genes coding for the enzymes included in this study are shown as underlined text. Abbreviations: <bold>B12</bold>, vitamin B12; <bold>BHMT,</bold> betaine-homocysteine methyltransferase; <bold>CBS</bold>, cystathionine beta synthase; <bold>DHF</bold>, dihydrofolate; <bold>DHFR</bold>, dihydrofolate reductase; <bold>dTMP</bold>, thymidine monophosphate; <bold>dUMP</bold>, uridine monophosphate; <bold>FAD</bold>, flavin adenine dinucleotide; <bold>GLY</bold>, glycine; <bold>MTHFD1</bold>, trifunctional methylenetetrahydrofolate dehydrogenase, cyclohydrolase, synthase; <bold>MTHFR</bold>, methylenetetrahydrofolate reductase; <bold>MTR</bold>, 5-methyltetrahydrofolate-homocysteine methyltransferase; <bold>MTRR</bold>, 5-methyltetrahydrofolate-homocysteine methyltransferase reductase; <bold>MT</bold>, methyl transferase; <bold>SAH</bold>, S-adenosylhomocysteine hydrolase; <bold>SER</bold>, serine; <bold>THF</bold>, tetrahydrofolate; <bold>TS</bold>, thymidylate synthase; <bold>5-CH3-THF</bold>, 5-methyl tetrahydrofolate; <bold>5,10-CH2=THF</bold>, methylene tetrahydrofolate; <bold>5,10=CH2-THF</bold>, methenyl tetrahydrofolate; <bold>10-CHO-THF</bold>, 10-formyl tetrahydrofolate.</p></caption><graphic xlink:href="mv-v14-2484-f1"/></fig><table-wrap id="t1" position="float"><label>Table 1</label><caption><title>Characteristics and genotype counts of the 17 SNPs in 5 homocysteine genes.</title></caption><table frame="hsides" rules="groups"><col width="58" span="1"/><col width="67" span="1"/><col width="31" span="1"/><col width="64" span="1"/><col width="46" span="1"/><col width="58" span="1"/><col width="63" span="1"/><col width="63" span="1"/><col width="63" span="1"/><thead><tr><th rowspan="2" valign="middle" align="center" scope="col" colspan="1"><bold>Gene</bold></th><th rowspan="2" valign="middle" align="center" scope="col" colspan="1"><bold>SNP</bold></th><th rowspan="2" valign="middle" align="center" scope="col" colspan="1"><bold>Chr</bold></th><th rowspan="2" valign="middle" align="center" scope="col" colspan="1"><bold>Position (bp)</bold></th><th rowspan="2" valign="middle" align="center" scope="col" colspan="1"><bold>Codon change</bold></th><th valign="middle" colspan="4" align="center" scope="colgroup" rowspan="1"><bold>Genotype count (AA/AB/BB)*</bold><hr/></th></tr><tr><th valign="middle" colspan="1" align="center" scope="colgroup" rowspan="1"><bold>PXFS</bold></th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1"><bold>PXFG</bold></th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1"><bold>PXFNG</bold></th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1"><bold>Controls</bold></th></tr></thead><tbody><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTHFR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1801131">rs1801131</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">1</td><td valign="middle" align="center" rowspan="1" colspan="1">11777063</td><td valign="middle" align="center" rowspan="1" colspan="1">E429A</td><td valign="middle" align="center" rowspan="1" colspan="1">13/29/37</td><td valign="middle" align="center" rowspan="1" colspan="1">11/20/26</td><td valign="middle" align="center" rowspan="1" colspan="1">2/9/11</td><td valign="middle" align="center" rowspan="1" colspan="1">9/19/22</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTHFR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1801133">rs1801133</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">1</td><td valign="middle" align="center" rowspan="1" colspan="1">11778965</td><td valign="middle" align="center" rowspan="1" colspan="1">A222V</td><td valign="middle" align="center" rowspan="1" colspan="1">10/41/33</td><td valign="middle" align="center" rowspan="1" colspan="1">7/31/23</td><td valign="middle" align="center" rowspan="1" colspan="1">3/10/10</td><td valign="middle" align="center" rowspan="1" colspan="1">7/22/21</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTHFR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=17037396">rs17037396</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">1</td><td valign="middle" align="center" rowspan="1" colspan="1">11784634</td><td valign="middle" align="center" rowspan="1" colspan="1">intron</td><td valign="middle" align="center" rowspan="1" colspan="1">0/15/71</td><td valign="middle" align="center" rowspan="1" colspan="1">0/13/46</td><td valign="middle" align="center" rowspan="1" colspan="1">0/2/25</td><td valign="middle" align="center" rowspan="1" colspan="1">0/17/73</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=12096955">rs12096955</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">1</td><td valign="middle" align="center" rowspan="1" colspan="1">235055726</td><td valign="middle" align="center" rowspan="1" colspan="1">intron</td><td valign="middle" align="center" rowspan="1" colspan="1">14/40/31</td><td valign="middle" align="center" rowspan="1" colspan="1">10/28/21</td><td valign="middle" align="center" rowspan="1" colspan="1">4/12/10</td><td valign="middle" align="center" rowspan="1" colspan="1">12/39/40</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2229274">rs2229274</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">1</td><td valign="middle" align="center" rowspan="1" colspan="1">235056807</td><td valign="middle" align="center" rowspan="1" colspan="1">D294N</td><td valign="middle" align="center" rowspan="1" colspan="1">0/3/80</td><td valign="middle" align="center" rowspan="1" colspan="1">0/2/59</td><td valign="middle" align="center" rowspan="1" colspan="1">0/1/21</td><td valign="middle" align="center" rowspan="1" colspan="1">0/4/53</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1805087">rs1805087</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">1</td><td valign="middle" align="center" rowspan="1" colspan="1">235115123</td><td valign="middle" align="center" rowspan="1" colspan="1">D919G</td><td valign="middle" align="center" rowspan="1" colspan="1">6/57/121</td><td valign="middle" align="center" rowspan="1" colspan="1">6/44/88</td><td valign="middle" align="center" rowspan="1" colspan="1">0/13/33</td><td valign="middle" align="center" rowspan="1" colspan="1">6/38/74</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTRR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=326122">rs326122</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">5</td><td valign="middle" align="center" rowspan="1" colspan="1">7929611</td><td valign="middle" align="center" rowspan="1" colspan="1">intron</td><td valign="middle" align="center" rowspan="1" colspan="1">2/29/53</td><td valign="middle" align="center" rowspan="1" colspan="1">1/20/37</td><td valign="middle" align="center" rowspan="1" colspan="1">1/9/16</td><td valign="middle" align="center" rowspan="1" colspan="1">5/22/62</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTRR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1532268">rs1532268</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">5</td><td valign="middle" align="center" rowspan="1" colspan="1">7931179</td><td valign="middle" align="center" rowspan="1" colspan="1">S202L</td><td valign="middle" align="center" rowspan="1" colspan="1">7/37/37</td><td valign="middle" align="center" rowspan="1" colspan="1">6/26/26</td><td valign="middle" align="center" rowspan="1" colspan="1">1/11/11</td><td valign="middle" align="center" rowspan="1" colspan="1">11/25/18</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTRR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=161870">rs161870</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">5</td><td valign="middle" align="center" rowspan="1" colspan="1">7931192</td><td valign="middle" align="center" rowspan="1" colspan="1">L206L</td><td valign="middle" align="center" rowspan="1" colspan="1">17/27/20</td><td valign="middle" align="center" rowspan="1" colspan="1">11/22/14</td><td valign="middle" align="center" rowspan="1" colspan="1">6/5/6</td><td valign="middle" align="center" rowspan="1" colspan="1">10/19/11</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTRR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=162036">rs162036</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">5</td><td valign="middle" align="center" rowspan="1" colspan="1">7938959</td><td valign="middle" align="center" rowspan="1" colspan="1">R377K</td><td valign="middle" align="center" rowspan="1" colspan="1">4/20/63</td><td valign="middle" align="center" rowspan="1" colspan="1">4/13/43</td><td valign="middle" align="center" rowspan="1" colspan="1">0/7/20</td><td valign="middle" align="center" rowspan="1" colspan="1">3/20/68</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTHFD1</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=8006686">rs8006686</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">14</td><td valign="middle" align="center" rowspan="1" colspan="1">63938424</td><td valign="middle" align="center" rowspan="1" colspan="1">intron</td><td valign="middle" align="center" rowspan="1" colspan="1">5/27/55</td><td valign="middle" align="center" rowspan="1" colspan="1">2/23/35</td><td valign="middle" align="center" rowspan="1" colspan="1">3/4/20</td><td valign="middle" align="center" rowspan="1" colspan="1">0/21/70</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTHFD1</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2236225">rs2236225</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">14</td><td valign="middle" align="center" rowspan="1" colspan="1">63978598</td><td valign="middle" align="center" rowspan="1" colspan="1">R653Q</td><td valign="middle" align="center" rowspan="1" colspan="1">34/96/51</td><td valign="middle" align="center" rowspan="1" colspan="1">24/71/42</td><td valign="middle" align="center" rowspan="1" colspan="1">10/25/9</td><td valign="middle" align="center" rowspan="1" colspan="1">30/52/35</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTHFD1</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11627387">rs11627387</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">14</td><td valign="middle" align="center" rowspan="1" colspan="1">63993730</td><td valign="middle" align="center" rowspan="1" colspan="1">intron</td><td valign="middle" align="center" rowspan="1" colspan="1">7/31/45</td><td valign="middle" align="center" rowspan="1" colspan="1">4/23/30</td><td valign="middle" align="center" rowspan="1" colspan="1">3/8/15</td><td valign="middle" align="center" rowspan="1" colspan="1">8/32/50</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>CBS</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2124459">rs2124459</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">21</td><td valign="middle" align="center" rowspan="1" colspan="1">43348783</td><td valign="middle" align="center" rowspan="1" colspan="1">intron</td><td valign="middle" align="center" rowspan="1" colspan="1">16/43/29</td><td valign="middle" align="center" rowspan="1" colspan="1">9/39/23</td><td valign="middle" align="center" rowspan="1" colspan="1">7/4/6</td><td valign="middle" align="center" rowspan="1" colspan="1">14/40/37</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>CBS</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1801181">rs1801181</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">21</td><td valign="middle" align="center" rowspan="1" colspan="1">43353685</td><td valign="middle" align="center" rowspan="1" colspan="1">A360A</td><td valign="middle" align="center" rowspan="1" colspan="1">21/75/77</td><td valign="middle" align="center" rowspan="1" colspan="1">13/60/58</td><td valign="middle" align="center" rowspan="1" colspan="1">8/15/19</td><td valign="middle" align="center" rowspan="1" colspan="1">14/43/49</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>CBS</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=5742905">rs5742905</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">21</td><td valign="middle" align="center" rowspan="1" colspan="1">43356253</td><td valign="middle" align="center" rowspan="1" colspan="1">I278T</td><td valign="middle" align="center" rowspan="1" colspan="1">1/32/151</td><td valign="middle" align="center" rowspan="1" colspan="1">1/25/112</td><td valign="middle" align="center" rowspan="1" colspan="1">0/7/39</td><td valign="middle" align="center" rowspan="1" colspan="1">2/10/96</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>CBS</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=234715">rs234715</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">21</td><td valign="middle" align="center" rowspan="1" colspan="1">43361464</td><td valign="middle" align="center" rowspan="1" colspan="1">intron</td><td valign="middle" align="center" rowspan="1" colspan="1">4/29/55</td><td valign="middle" align="center" rowspan="1" colspan="1">3/25/43</td><td valign="middle" align="center" rowspan="1" colspan="1">1/4/12</td><td valign="middle" align="center" rowspan="1" colspan="1">5/30/54</td></tr></tbody></table><table-wrap-foot><p>The asterisk indicates that &#x0201c;A&#x0201d; represents the minor allele and &#x0201c;B&#x0201d; represents the common allele.</p></table-wrap-foot></table-wrap></sec><sec><title>Statistical analysis</title><p>Statistical analyses were performed using <ext-link ext-link-type="uri" xlink:href="http://pngu.mgh.harvard.edu/~purcell/plink/">PLINK</ext-link> (version 1.04) [<xref ref-type="bibr" rid="r30">30</xref>]. Hardy&#x02013;Weinberg equilibrium was assessed by the &#x003c7;<sup>2</sup> test. Linkage disequilibrium was measured using r<sup>2</sup>. Initial single-SNP association analysis was performed using the Fisher's exact test. Multivariable analysis of individual SNPs was performed using logistic regression models. The additive effects model was applied to analysis of allele dosage in which the genotypes AA, AB, BB were coded as 0, 1, 2, respectively, where A represents the minor allele and B represents the common allele. After controlling for the effects of age and three significant <italic>LOXL1</italic> SNPs (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link>), individual SNPs in the homocysteine genes were analyzed for association with PXFS using logistic regression. Interaction analysis of pair-wise SNPs between the homocysteine SNPs and the <italic>LOXL1</italic> SNPs was performed by including an interaction term in the logistic regression models. Haplotype analysis and the set-based test were used to test for association of individual genes. Haplotype frequencies were estimated using the standard E-M algorithm and tested using the &#x003c7;<sup>2</sup> test. The omnibus p-values for haplotype analysis were obtained from the omnibus test. The set-based test selects the best set of SNPs whose mean of these single SNP statistics is significant after permutation, which is particularly suited to large-scale candidate gene studies [<xref ref-type="bibr" rid="r31">31</xref>]. The empirical p values of the set-based test were obtained by a permutation of 10,000 times of phenotype labels. Multiple comparisons were corrected using the Bonferroni method.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Single-SNP association analysis</title><p>Seventeen SNPs in five genes were analyzed for association with PXFS, PXFG, and PXFNG (<xref ref-type="table" rid="t1">Table 1</xref>). All of these SNPs followed Hardy&#x02013;Weinberg equilibrium in both cases and controls (p&#x0003e;0.05). The selected SNPs were not in strong LD (r<sup>2</sup>&#x0003c;0.26), which is consistent with the HapMap data from the CEU population. Only one SNP, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=8006686">rs8006686</ext-link> in <italic>MTHFD1</italic>, showed a marginally significant association with PXFS (p=0.015; OR=2.07, 95%CI: 1.16, 3.71) and PXFG (p=0.015; OR=2.23, 95%CI: 1.19, 4.16). However, none of these SNPs were significantly associated with PXFS, PXFG or PXFNG after correcting for multiple comparisons (Bonferroni corrected p&#x0003e;0.25; <xref ref-type="table" rid="t2">Table 2</xref>).</p><table-wrap id="t2" position="float"><label>Table 2</label><caption><title>Single-SNP association of homocysteine genes with PXFS, PXFG and PXFNG.</title></caption><table frame="hsides" rules="groups"><col width="59" span="1"/><col width="72" span="1"/><col width="45" span="1"/><col width="45" span="1"/><col width="45" span="1"/><col width="58" span="1"/><col width="57" span="1"/><col width="43" span="1"/><col width="45" span="1"/><col width="54" span="1"/><thead><tr><th rowspan="2" valign="middle" align="center" scope="col" colspan="1"><bold>Gene</bold></th><th rowspan="2" valign="middle" align="center" scope="col" colspan="1"><bold>SNP</bold></th><th rowspan="2" valign="middle" align="center" scope="col" colspan="1"><bold>Minor allele</bold></th><th valign="middle" colspan="4" align="center" scope="colgroup" rowspan="1"><bold>Minor allele frequency</bold><hr/></th><th valign="middle" colspan="3" align="center" scope="colgroup" rowspan="1"><bold>p value*</bold><hr/></th></tr><tr><th valign="middle" colspan="1" align="center" scope="colgroup" rowspan="1"><bold>PXFS</bold></th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1"><bold>PXFG</bold></th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1"><bold>PXFNG</bold></th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1"><bold>Controls</bold></th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1"><bold>PXFS</bold></th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1"><bold>PXFG</bold></th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1"><bold>PXFNG</bold></th></tr></thead><tbody><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTHFR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1801131">rs1801131</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">C</td><td valign="middle" align="center" rowspan="1" colspan="1">0.348</td><td valign="middle" align="center" rowspan="1" colspan="1">0.368</td><td valign="middle" align="center" rowspan="1" colspan="1">0.295</td><td valign="middle" align="center" rowspan="1" colspan="1">0.370</td><td valign="middle" align="center" rowspan="1" colspan="1">0.79</td><td valign="middle" align="center" rowspan="1" colspan="1">1.00</td><td valign="middle" align="center" rowspan="1" colspan="1">0.45</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTHFR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1801133">rs1801133</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">T</td><td valign="middle" align="center" rowspan="1" colspan="1">0.363</td><td valign="middle" align="center" rowspan="1" colspan="1">0.369</td><td valign="middle" align="center" rowspan="1" colspan="1">0.348</td><td valign="middle" align="center" rowspan="1" colspan="1">0.360</td><td valign="middle" align="center" rowspan="1" colspan="1">1.00</td><td valign="middle" align="center" rowspan="1" colspan="1">1.00</td><td valign="middle" align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTHFR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=17037396">rs17037396</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">T</td><td valign="middle" align="center" rowspan="1" colspan="1">0.087</td><td valign="middle" align="center" rowspan="1" colspan="1">0.110</td><td valign="middle" align="center" rowspan="1" colspan="1">0.037</td><td valign="middle" align="center" rowspan="1" colspan="1">0.094</td><td valign="middle" align="center" rowspan="1" colspan="1">0.85</td><td valign="middle" align="center" rowspan="1" colspan="1">0.70</td><td valign="middle" align="center" rowspan="1" colspan="1">0.26</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=12096955">rs12096955</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">T</td><td valign="middle" align="center" rowspan="1" colspan="1">0.400</td><td valign="middle" align="center" rowspan="1" colspan="1">0.407</td><td valign="middle" align="center" rowspan="1" colspan="1">0.385</td><td valign="middle" align="center" rowspan="1" colspan="1">0.346</td><td valign="middle" align="center" rowspan="1" colspan="1">0.32</td><td valign="middle" align="center" rowspan="1" colspan="1">0.33</td><td valign="middle" align="center" rowspan="1" colspan="1">0.62</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2229274">rs2229274</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">A</td><td valign="middle" align="center" rowspan="1" colspan="1">0.018</td><td valign="middle" align="center" rowspan="1" colspan="1">0.016</td><td valign="middle" align="center" rowspan="1" colspan="1">0.023</td><td valign="middle" align="center" rowspan="1" colspan="1">0.035</td><td valign="middle" align="center" rowspan="1" colspan="1">0.45</td><td valign="middle" align="center" rowspan="1" colspan="1">0.43</td><td valign="middle" align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1805087">rs1805087</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">G</td><td valign="middle" align="center" rowspan="1" colspan="1">0.188</td><td valign="middle" align="center" rowspan="1" colspan="1">0.203</td><td valign="middle" align="center" rowspan="1" colspan="1">0.141</td><td valign="middle" align="center" rowspan="1" colspan="1">0.212</td><td valign="middle" align="center" rowspan="1" colspan="1">0.47</td><td valign="middle" align="center" rowspan="1" colspan="1">0.83</td><td valign="middle" align="center" rowspan="1" colspan="1">0.16</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTRR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=326122">rs326122</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">G</td><td valign="middle" align="center" rowspan="1" colspan="1">0.196</td><td valign="middle" align="center" rowspan="1" colspan="1">0.190</td><td valign="middle" align="center" rowspan="1" colspan="1">0.212</td><td valign="middle" align="center" rowspan="1" colspan="1">0.180</td><td valign="middle" align="center" rowspan="1" colspan="1">0.78</td><td valign="middle" align="center" rowspan="1" colspan="1">0.88</td><td valign="middle" align="center" rowspan="1" colspan="1">0.69</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTRR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1532268">rs1532268</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">T</td><td valign="middle" align="center" rowspan="1" colspan="1">0.315</td><td valign="middle" align="center" rowspan="1" colspan="1">0.328</td><td valign="middle" align="center" rowspan="1" colspan="1">0.283</td><td valign="middle" align="center" rowspan="1" colspan="1">0.435</td><td valign="middle" align="center" rowspan="1" colspan="1">0.053</td><td valign="middle" align="center" rowspan="1" colspan="1">0.10</td><td valign="middle" align="center" rowspan="1" colspan="1">0.10</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTRR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=161870">rs161870</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">A</td><td valign="middle" align="center" rowspan="1" colspan="1">0.477</td><td valign="middle" align="center" rowspan="1" colspan="1">0.468</td><td valign="middle" align="center" rowspan="1" colspan="1">0.500</td><td valign="middle" align="center" rowspan="1" colspan="1">0.488</td><td valign="middle" align="center" rowspan="1" colspan="1">0.89</td><td valign="middle" align="center" rowspan="1" colspan="1">0.88</td><td valign="middle" align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTRR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=162036">rs162036</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">A</td><td valign="middle" align="center" rowspan="1" colspan="1">0.161</td><td valign="middle" align="center" rowspan="1" colspan="1">0.175</td><td valign="middle" align="center" rowspan="1" colspan="1">0.130</td><td valign="middle" align="center" rowspan="1" colspan="1">0.143</td><td valign="middle" align="center" rowspan="1" colspan="1">0.66</td><td valign="middle" align="center" rowspan="1" colspan="1">0.52</td><td valign="middle" align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTHFD1</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=8006686">rs8006686</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">C</td><td valign="middle" align="center" rowspan="1" colspan="1">0.213</td><td valign="middle" align="center" rowspan="1" colspan="1">0.225</td><td valign="middle" align="center" rowspan="1" colspan="1">0.185</td><td valign="middle" align="center" rowspan="1" colspan="1">0.115</td><td valign="middle" align="center" rowspan="1" colspan="1">0.015</td><td valign="middle" align="center" rowspan="1" colspan="1">0.015</td><td valign="middle" align="center" rowspan="1" colspan="1">0.25</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTHFD1</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2236225">rs2236225</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">T</td><td valign="middle" align="center" rowspan="1" colspan="1">0.453</td><td valign="middle" align="center" rowspan="1" colspan="1">0.434</td><td valign="middle" align="center" rowspan="1" colspan="1">0.489</td><td valign="middle" align="center" rowspan="1" colspan="1">0.479</td><td valign="middle" align="center" rowspan="1" colspan="1">0.56</td><td valign="middle" align="center" rowspan="1" colspan="1">0.33</td><td valign="middle" align="center" rowspan="1" colspan="1">0.62</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTHFD1</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11627387">rs11627387</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">G</td><td valign="middle" align="center" rowspan="1" colspan="1">0.271</td><td valign="middle" align="center" rowspan="1" colspan="1">0.272</td><td valign="middle" align="center" rowspan="1" colspan="1">0.269</td><td valign="middle" align="center" rowspan="1" colspan="1">0.267</td><td valign="middle" align="center" rowspan="1" colspan="1">1.00</td><td valign="middle" align="center" rowspan="1" colspan="1">1.00</td><td valign="middle" align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>CBS</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2124459">rs2124459</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">C</td><td valign="middle" align="center" rowspan="1" colspan="1">0.426</td><td valign="middle" align="center" rowspan="1" colspan="1">0.401</td><td valign="middle" align="center" rowspan="1" colspan="1">0.471</td><td valign="middle" align="center" rowspan="1" colspan="1">0.374</td><td valign="middle" align="center" rowspan="1" colspan="1">0.33</td><td valign="middle" align="center" rowspan="1" colspan="1">0.65</td><td valign="middle" align="center" rowspan="1" colspan="1">0.13</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>CBS</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1801181">rs1801181</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">T</td><td valign="middle" align="center" rowspan="1" colspan="1">0.338</td><td valign="middle" align="center" rowspan="1" colspan="1">0.328</td><td valign="middle" align="center" rowspan="1" colspan="1">0.369</td><td valign="middle" align="center" rowspan="1" colspan="1">0.335</td><td valign="middle" align="center" rowspan="1" colspan="1">1.00</td><td valign="middle" align="center" rowspan="1" colspan="1">0.92</td><td valign="middle" align="center" rowspan="1" colspan="1">0.59</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>CBS</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=5742905">rs5742905</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">C</td><td valign="middle" align="center" rowspan="1" colspan="1">0.092</td><td valign="middle" align="center" rowspan="1" colspan="1">0.098</td><td valign="middle" align="center" rowspan="1" colspan="1">0.076</td><td valign="middle" align="center" rowspan="1" colspan="1">0.065</td><td valign="middle" align="center" rowspan="1" colspan="1">0.28</td><td valign="middle" align="center" rowspan="1" colspan="1">0.25</td><td valign="middle" align="center" rowspan="1" colspan="1">0.81</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>CBS</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=234715">rs234715</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">G</td><td valign="middle" align="center" rowspan="1" colspan="1">0.210</td><td valign="middle" align="center" rowspan="1" colspan="1">0.218</td><td valign="middle" align="center" rowspan="1" colspan="1">0.176</td><td valign="middle" align="center" rowspan="1" colspan="1">0.225</td><td valign="middle" align="center" rowspan="1" colspan="1">0.80</td><td valign="middle" align="center" rowspan="1" colspan="1">1.00</td><td valign="middle" align="center" rowspan="1" colspan="1">0.65</td></tr></tbody></table><table-wrap-foot><p>The asterisk indicates that p values were obtained from Fisher&#x02019;s exact test when compared to controls. The Bonferroni corrected significance level was 0.003 (0.05/17).</p></table-wrap-foot></table-wrap><p>After controlling for the effects of age and the three significant <italic>LOXL1</italic> SNPs (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link>), logistic regression analysis also showed that none of the SNPs in the homocysteine genes were associated with PXFS (p&#x0003e;0.12; <xref ref-type="table" rid="t3">Table 3</xref>). No significant interaction effects on PXFS were found between the homocysteine SNPs and the <italic>LOXL1</italic> SNPs (p&#x0003e;0.06; data not shown).</p><table-wrap id="t3" position="float"><label>Table 3</label><caption><title>Single-SNP association of homocysteine genes with PXFS after controlling for the effects of age and 3 <italic>LOXL1</italic> SNPs.</title></caption><table frame="hsides" rules="groups"><col width="78" span="1"/><col width="81" span="1"/><col width="56" span="1"/><col width="58" span="1"/><col width="115" span="1"/><thead><tr><th valign="middle" align="center" scope="col" rowspan="1" colspan="1"><bold>Gene</bold></th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1"><bold>SNP</bold></th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1"><bold>Minor allele</bold></th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1"><bold>p value*</bold></th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1"><bold>OR (95% CI)*</bold></th></tr></thead><tbody><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTHFR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1801131">rs1801131</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">C</td><td valign="middle" align="center" rowspan="1" colspan="1">0.95</td><td valign="middle" align="center" rowspan="1" colspan="1">0.98 (0.49, 1.96)</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTHFR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1801133">rs1801133</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">T</td><td valign="middle" align="center" rowspan="1" colspan="1">0.55</td><td valign="middle" align="center" rowspan="1" colspan="1">0.79 (0.37, 1.70)</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTHFR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=17037396">rs17037396</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">T</td><td valign="middle" align="center" rowspan="1" colspan="1">0.81</td><td valign="middle" align="center" rowspan="1" colspan="1">0.89 (0.33, 2.40)</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=12096955">rs12096955</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">T</td><td valign="middle" align="center" rowspan="1" colspan="1">0.23</td><td valign="middle" align="center" rowspan="1" colspan="1">1.43 (0.80, 2.54)</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2229274">rs2229274</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">A</td><td valign="middle" align="center" rowspan="1" colspan="1">0.55</td><td valign="middle" align="center" rowspan="1" colspan="1">0.52 (0.06, 4.41)</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1805087">rs1805087</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">G</td><td valign="middle" align="center" rowspan="1" colspan="1">0.69</td><td valign="middle" align="center" rowspan="1" colspan="1">0.90 (0.52, 1.55)</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTRR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=326122">rs326122</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">G</td><td valign="middle" align="center" rowspan="1" colspan="1">0.95</td><td valign="middle" align="center" rowspan="1" colspan="1">1.02 (0.50, 2.07)</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTRR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1532268">rs1532268</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">T</td><td valign="middle" align="center" rowspan="1" colspan="1">0.82</td><td valign="middle" align="center" rowspan="1" colspan="1">1.09 (0.50, 2.38)</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTRR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=161870">rs161870</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">A</td><td valign="middle" align="center" rowspan="1" colspan="1">0.46</td><td valign="middle" align="center" rowspan="1" colspan="1">0.74 (0.33, 1.65)</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTRR</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=162036">rs162036</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">A</td><td valign="middle" align="center" rowspan="1" colspan="1">0.91</td><td valign="middle" align="center" rowspan="1" colspan="1">0.96 (0.49, 1.90)</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTHFD1</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=8006686">rs8006686</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">C</td><td valign="middle" align="center" rowspan="1" colspan="1">0.21</td><td valign="middle" align="center" rowspan="1" colspan="1">1.62 (0.76, 3.45)</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTHFD1</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2236225">rs2236225</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">T</td><td valign="middle" align="center" rowspan="1" colspan="1">0.77</td><td valign="middle" align="center" rowspan="1" colspan="1">0.93 (0.59, 1.47)</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTHFD1</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11627387">rs11627387</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">G</td><td valign="middle" align="center" rowspan="1" colspan="1">0.24</td><td valign="middle" align="center" rowspan="1" colspan="1">0.68 (0.36, 1.29)</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>CBS</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2124459">rs2124459</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">C</td><td valign="middle" align="center" rowspan="1" colspan="1">0.71</td><td valign="middle" align="center" rowspan="1" colspan="1">1.13 (0.61, 2.10)</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>CBS</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1801181">rs1801181</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">T</td><td valign="middle" align="center" rowspan="1" colspan="1">0.49</td><td valign="middle" align="center" rowspan="1" colspan="1">1.18 (0.74, 1.89)</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>CBS</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=5742905">rs5742905</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">C</td><td valign="middle" align="center" rowspan="1" colspan="1">0.12</td><td valign="middle" align="center" rowspan="1" colspan="1">2.07 (0.84, 5.14)</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>CBS</italic></td><td valign="middle" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=234715">rs234715</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">G</td><td valign="middle" align="center" rowspan="1" colspan="1">0.57</td><td valign="middle" align="center" rowspan="1" colspan="1">0.80 (0.36, 1.74)</td></tr></tbody></table><table-wrap-foot><p>The asterisk indicates that p values and odds ratios (OR) with 95% confidence intervals (CI) were obtained from logistic regression analysis of single-SNP association of homocysteine genes with PXFS after controlling for the effects of age and the 3 <italic>LOXL1</italic> SNPs (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link>).</p></table-wrap-foot></table-wrap></sec><sec><title>Gene-based association analysis</title><p>Haplotype association analysis of all the tag SNPs in each gene revealed no association of individual genes with PXFS (omnibus p&#x0003e;0.23; <xref ref-type="table" rid="t4">Table 4</xref>). Set-based association tests also did not identify significant association of individual genes with PXFS (empirical p&#x0003e;0.04, Bonferroni corrected p&#x0003e;0.20; <xref ref-type="table" rid="t4">Table 4</xref>).</p><table-wrap id="t4" position="float"><label>Table 4</label><caption><title>Gene-based association of homocysteine genes with PXFS.</title></caption><table frame="hsides" rules="groups"><col width="63" span="1"/><col width="235" span="1"/><col width="96" span="1"/><col width="88" span="1"/><thead><tr><th rowspan="2" valign="middle" align="center" scope="col" colspan="1"><bold>Gene</bold></th><th rowspan="2" valign="middle" align="center" scope="col" colspan="1"><bold>SNPs</bold></th><th valign="middle" colspan="2" align="center" scope="colgroup" rowspan="1"><bold>p value</bold><hr/></th></tr><tr><th valign="middle" colspan="1" align="center" scope="colgroup" rowspan="1"><bold>Haplotype test*</bold></th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1"><bold>Set-based test<sup>#</sup></bold></th></tr></thead><tbody><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTHFR</italic></td><td valign="middle" align="center" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1801131">rs1801131</ext-link>&#x02028;, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1801133">rs1801133</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=17037396">rs17037396</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">0.97</td><td valign="middle" align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTR</italic></td><td valign="middle" align="center" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=12096955">rs12096955</ext-link>&#x02028;, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2229274">rs2229274</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1805087">rs1805087</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">0.68</td><td valign="middle" align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTRR</italic></td><td valign="middle" align="center" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=326122">rs326122</ext-link>&#x02028;, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1532268">rs1532268</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=161870">rs161870</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=162036">rs162036</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">0.85</td><td valign="middle" align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>MTHFD1</italic></td><td valign="middle" align="center" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=8006686">rs8006686</ext-link>&#x02028;, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2236225">rs2236225</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11627387">rs11627387</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">0.30</td><td valign="middle" align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1"><italic>CBS</italic></td><td valign="middle" align="center" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2124459">rs2124459</ext-link>&#x02028;, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1801181">rs1801181</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=5742905">rs5742905</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=234715">rs234715</ext-link></td><td valign="middle" align="center" rowspan="1" colspan="1">0.23</td><td valign="middle" align="center" rowspan="1" colspan="1">1.00</td></tr></tbody></table><table-wrap-foot><p>The asterisk indicates that the p values were obtained from the omnibus haplotype test using PLINK (version 1.04) [<xref ref-type="bibr" rid="r30">30</xref>] and the the sharp (hash mark) indicates that the p values were obtained from the set-based test by a permutation of 10,000 times using PLINK (version 1.04) [<xref ref-type="bibr" rid="r30">30</xref>]. The Bonferroni corrected significance level was 0.01 (0.05/5).</p></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Recent studies suggest that <italic>LOXL1</italic> is a major gene associated with PXFS/PXFG, contributing to the majority of cases in most populations [<xref ref-type="bibr" rid="r8">8</xref>-<xref ref-type="bibr" rid="r22">22</xref>]. However, the high prevalence of the <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> risk allele in control populations, and the apparent variable penetrance of the condition in some populations suggest that additional genetic factors and/or environmental exposures could be involved in the development of this complex disease. As moderate hyperhomocysteinemia has been repeatedly described in PXFS and PXFG patients [<xref ref-type="bibr" rid="r24">24</xref>-<xref ref-type="bibr" rid="r26">26</xref>], we evaluated the genes that code for proteins involved in homocysteine metabolism as candidates for secondary factors contributing to this disease.</p><p>Multiple reports have indicated that patients with PXFS have mild elevations of homocysteine in serum plasma, as well as aqueous humor and tear fluid [<xref ref-type="bibr" rid="r24">24</xref>-<xref ref-type="bibr" rid="r26">26</xref>]. As the association of hyperhomocysteinemia with vascular disease has been well documented [<xref ref-type="bibr" rid="r28">28</xref>], and ocular and systemic blood vessels in PXFS can be abnormal [<xref ref-type="bibr" rid="r32">32</xref>], we hypothesized that elevated homocysteine caused by variant forms of genes coding for key enzymes involved in homocysteine metabolism could contribute to the PXFS. Defects in LOXL1 can also compromise the elastic structure of blood vessels [<xref ref-type="bibr" rid="r33">33</xref>], and that the combined effects of elevated serum homocysteine and LOXL1 deficiency could synergistically contribute to vascular compromise. Abnormalities of ocular vasculature, especially blood vessels in the iris could be related to the deposition of the microfibrillar material that is characteristic of the disease process. Previous studies have failed to show an association between homocysteine metabolism genes and PXFS [<xref ref-type="bibr" rid="r34">34</xref>-<xref ref-type="bibr" rid="r39">39</xref>], however these studies have evaluated only the well studied common C677T polymorphism (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1801133">rs1801133</ext-link>) in <italic>MTHFR</italic>, a central regulator of homocysteine levels. In this study we took a broader approach and evaluated 5 genes involved in homocysteine metabolism, including the <italic>MTHFR</italic> gene. We did not find any significant association between any of the homocysteine genes and PXFS and/or PXFG in this present study.</p><p>Cystathionine &#x003b2;-synthase catalyzes the transsulfuration of homocysteine to cystathionine. The <italic>CBS</italic> c.844_845ins68 mutation has been associated with increased CBS enzyme activity and decreased homocysteine levels [<xref ref-type="bibr" rid="r40">40</xref>,<xref ref-type="bibr" rid="r41">41</xref>], and has been hypothesized to have a protective effect against vascular thromboembolic disease [<xref ref-type="bibr" rid="r42">42</xref>]. We initially sequenced a sample of 100 patients with PXFS and 100 controls and observed that another <italic>CBS</italic> variant, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=5742905">rs5742905</ext-link> (I278T), was in complete linkage disequilibrium with c.844_845ins68 (r<sup>2</sup>=1.0). We therefore considered <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=5742905">rs5742905</ext-link> as a surrogate for c.844_845ins68 and only genotyped <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=5742905">rs5742905</ext-link> in our subsequent samples using TaqMan assays. In our population, we did not find any association of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=5742905">rs5742905</ext-link> with PXFS or PXFG, and so did the c.844_845ins68 mutation.</p><p>As age and <italic>LOXL1</italic> variants are two known major risk factors for PXFS and PXFG, we analyzed the association between SNPs in homocysteine metabolism genes and PXFS and PXFG using logistic regression after controlling for the effects of age and the <italic>LOXL1</italic> variants. The <italic>MTHFD1</italic> SNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=8006686">rs8006686</ext-link> was marginally associated with PXFG before correction for multiple comparisons (p=0.015; <xref ref-type="table" rid="t2">Table 2</xref>). However, this association disappeared after controlling for the effects of age and the <italic>LOXL1</italic> variants (p=0.21; <xref ref-type="table" rid="t3">Table 3</xref>). To increase the statistical power to identify a possible association, we further analyzed our data using haplotype analysis and the set-based test, both of which are gene-based tests where all SNPs in a gene are analyzed together. The set-based test is particularly suited to large-scale candidate gene studies [<xref ref-type="bibr" rid="r31">31</xref>]. This method selects the best set of SNPs whose mean statistic is significant, leading to the inference that the entire set of SNPs might be interacting in some way to increase disease risk, or else that they are all contributing independently to disease risk. In the present study, both haplotype analysis and the set-based test did not find any significant association between the homocysteine genes and PXFS or PXFG (<xref ref-type="table" rid="t4">Table 4</xref>), in agreement with the logistic regression analysis of single SNPs in the homocysteine genes after controlling for the effects of age and the <italic>LOXL1</italic> variants (<xref ref-type="table" rid="t3">Table 3</xref>).</p><p>We estimated that the present study had 86% of power to detect a moderate genetic effect (genotypic relative risk of 2.0 for Aa and 4.0 for AA, given an additive risk model) [<xref ref-type="bibr" rid="r43">43</xref>]. However, this study had only 40% of the power needed to detect a mild genetic effect (genotypic relative risk of 1.5 for Aa and 2.25 for AA, given an additive risk model). In addition, since we used tag SNPs to capture the majority of the variants in each gene, it is possible that we might have missed other variants in these genes associated with the disease. Further large-scale studies and resequencing of the whole genes are warranted to confirm our findings.</p><p>Dietary factors that are important regulators of homocysteine metabolism have also been shown to be abnormal in PXFS and PXFG patients including low levels of B6, B12, and folate [<xref ref-type="bibr" rid="r44">44</xref>]. It is possible that diets that are low in these vitamins may contribute to these conditons by causing and elevation of homocysteine levels with subsequent interaction with the vascular insult caused by defective LOXL1. Although further documentation is necessary before disease risks can be determined, individuals who are carriers of the <italic>LOXL1</italic> at risk genotypes should be encouraged to maintain adequate levels of B6, B12, and folate in their diet.</p><p>In summary, five genes that code for critical components of the homocysteine metabolism pathway were evaluated as secondary factors for PXFS/PXFG in the present study. Our results suggest that variants in these genes are not major risk factors for the development of these conditions. Other important regulators of homocysteine metabolism, such as dietary intake of B6, B12, and folate may be contributing secondary environmental factors. Further studies searching for secondary genetic and environmental factors that contribute to PXFS and PXFG are required to gain a better understanding of the complex etiology of this important ocular disease.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported in part by NIH Grants EY015882 and P30EY014104.</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ritch</surname><given-names>R</given-names></name><name><surname>Schl&#x000f6;tzer-Schrehardt</surname><given-names>U</given-names></name><name><surname>Konstas</surname><given-names>AG</given-names></name></person-group><article-title>Why is glaucoma associated with exfoliation syndrome?</article-title><source>Prog Retin Eye Res</source><year>2003</year><volume>22</volume><fpage>253</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">12852486</pub-id></citation></ref><ref id="r2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schl&#x000f6;tzer-Schrehardt</surname><given-names>U</given-names></name><name><surname>Naumann</surname><given-names>GO</given-names></name></person-group><article-title>Ocular and systemic pseudoexfoliation syndrome.</article-title><source>Am J Ophthalmol</source><year>2006</year><volume>141</volume><fpage>921</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">16678509</pub-id></citation></ref><ref id="r3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jeng</surname><given-names>SM</given-names></name><name><surname>Karger</surname><given-names>RA</given-names></name><name><surname>Hodge</surname><given-names>DO</given-names></name><name><surname>Burke</surname><given-names>JP</given-names></name><name><surname>Johnson</surname><given-names>DH</given-names></name><name><surname>Good</surname><given-names>MS</given-names></name></person-group><article-title>The risk of glaucoma in pseudoexfoliation syndrome.</article-title><source>J Glaucoma</source><year>2007</year><volume>16</volume><fpage>117</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">17224761</pub-id></citation></ref><ref id="r4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Budde</surname><given-names>WM</given-names></name><name><surname>Jonas</surname><given-names>JB</given-names></name></person-group><article-title>Family history of glaucoma in the primary and secondary open-angle glaucomas.</article-title><source>Graefes Arch Clin Exp Ophthalmol</source><year>1999</year><volume>237</volume><fpage>554</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">10424305</pub-id></citation></ref><ref id="r5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Damji</surname><given-names>KF</given-names></name><name><surname>Bains</surname><given-names>HS</given-names></name><name><surname>Amjadi</surname><given-names>K</given-names></name><name><surname>Dohadwala</surname><given-names>AA</given-names></name><name><surname>Valberg</surname><given-names>JD</given-names></name><name><surname>Chevrier</surname><given-names>R</given-names></name><name><surname>Gould</surname><given-names>LF</given-names></name><name><surname>Zackon</surname><given-names>DH</given-names></name><name><surname>Addison</surname><given-names>DJ</given-names></name></person-group><article-title>Familial occurrence of pseudoexfoliation in Canada.</article-title><source>Can J Ophthalmol</source><year>1999</year><volume>34</volume><fpage>257</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">10486684</pub-id></citation></ref><ref id="r6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Allingham</surname><given-names>RR</given-names></name><name><surname>Loftsdottir</surname><given-names>M</given-names></name><name><surname>Gottfredsdottir</surname><given-names>MS</given-names></name><name><surname>Thorgeirsson</surname><given-names>E</given-names></name><name><surname>Jonasson</surname><given-names>F</given-names></name><name><surname>Sverisson</surname><given-names>T</given-names></name><name><surname>Hodge</surname><given-names>WG</given-names></name><name><surname>Damji</surname><given-names>KF</given-names></name><name><surname>Stef&#x000e1;nsson</surname><given-names>E</given-names></name></person-group><article-title>Pseudoexfoliation syndrome in Icelandic families.</article-title><source>Br J Ophthalmol</source><year>2001</year><volume>85</volume><fpage>702</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11371492</pub-id></citation></ref><ref id="r7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lemmela</surname><given-names>S</given-names></name><name><surname>Forsman</surname><given-names>E</given-names></name><name><surname>Sistonen</surname><given-names>P</given-names></name><name><surname>Eriksson</surname><given-names>A</given-names></name><name><surname>Forsius</surname><given-names>H</given-names></name><name><surname>Jarvela</surname><given-names>I</given-names></name></person-group><article-title>Genome-wide scan of exfoliation syndrome.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2007</year><volume>48</volume><fpage>4136</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">17724198</pub-id></citation></ref><ref id="r8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Magnusson</surname><given-names>KP</given-names></name><name><surname>Sulem</surname><given-names>P</given-names></name><name><surname>Walters</surname><given-names>GB</given-names></name><name><surname>Gudbjartsson</surname><given-names>DF</given-names></name><name><surname>Stefansson</surname><given-names>H</given-names></name><name><surname>Jonsson</surname><given-names>T</given-names></name><name><surname>Jonasdottir</surname><given-names>A</given-names></name><name><surname>Jonasdottir</surname><given-names>A</given-names></name><name><surname>Stefansdottir</surname><given-names>G</given-names></name><name><surname>Masson</surname><given-names>G</given-names></name><name><surname>Hardarson</surname><given-names>GA</given-names></name><name><surname>Petursson</surname><given-names>H</given-names></name><name><surname>Arnarsson</surname><given-names>A</given-names></name><name><surname>Motallebipour</surname><given-names>M</given-names></name><name><surname>Wallerman</surname><given-names>O</given-names></name><name><surname>Wadelius</surname><given-names>C</given-names></name><name><surname>Gulcher</surname><given-names>JR</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><name><surname>Kong</surname><given-names>A</given-names></name><name><surname>Jonasson</surname><given-names>F</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name></person-group><article-title>Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma.</article-title><source>Science</source><year>2007</year><volume>317</volume><fpage>1397</fpage><lpage>400</lpage><pub-id pub-id-type="pmid">17690259</pub-id></citation></ref><ref id="r9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>BJ</given-names></name><name><surname>Pasquale</surname><given-names>L</given-names></name><name><surname>Grosskreutz</surname><given-names>CL</given-names></name><name><surname>Rhee</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>DeAngelis</surname><given-names>MM</given-names></name><name><surname>Kim</surname><given-names>I</given-names></name><name><surname>del Bono</surname><given-names>E</given-names></name><name><surname>Miller</surname><given-names>JW</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Haines</surname><given-names>JL</given-names></name><name><surname>Wiggs</surname><given-names>JL</given-names></name></person-group><article-title>DNA sequence variants in the LOXL1 gene are associated with pseudoexfoliation glaucoma in a U.S. clinic-based population with broad ethnic diversity.</article-title><source>BMC Med Genet</source><year>2008</year><volume>9</volume><fpage>5</fpage><pub-id pub-id-type="pmid">18254956</pub-id></citation></ref><ref id="r10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fingert</surname><given-names>JH</given-names></name><name><surname>Alward</surname><given-names>WL</given-names></name><name><surname>Kwon</surname><given-names>YH</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Streb</surname><given-names>LM</given-names></name><name><surname>Sheffield</surname><given-names>VC</given-names></name><name><surname>Stone</surname><given-names>EM</given-names></name></person-group><article-title>LOXL1 mutations are associated with exfoliation syndrome in patients from the midwestern United States.</article-title><source>Am J Ophthalmol</source><year>2007</year><volume>144</volume><fpage>974</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">18036875</pub-id></citation></ref><ref id="r11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Challa</surname><given-names>P</given-names></name><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Qin</surname><given-names>X</given-names></name><name><surname>Vann</surname><given-names>RR</given-names></name><name><surname>Gonzalez</surname><given-names>P</given-names></name><name><surname>Allingham</surname><given-names>RR</given-names></name><name><surname>Hauser</surname><given-names>MA</given-names></name></person-group><article-title>Analysis of LOXL1 polymorphisms in a United States population with pseudoexfoliation glaucoma.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>146</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18334928</pub-id></citation></ref><ref id="r12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Zabriskie</surname><given-names>NA</given-names></name><name><surname>Hau</surname><given-names>VS</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Tong</surname><given-names>Z</given-names></name><name><surname>Gibbs</surname><given-names>D</given-names></name><name><surname>Farhi</surname><given-names>P</given-names></name><name><surname>Katz</surname><given-names>BJ</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Pearson</surname><given-names>E</given-names></name><name><surname>Goldsmith</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Kaminoh</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>Zeng</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name></person-group><article-title>Genetic association of LOXL1 gene variants and exfoliation glaucoma in a Utah cohort.</article-title><source>Cell Cycle</source><year>2008</year><volume>7</volume><fpage>521</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">18287813</pub-id></citation></ref><ref id="r13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aragon-Martin</surname><given-names>JA</given-names></name><name><surname>Ritch</surname><given-names>R</given-names></name><name><surname>Liebmann</surname><given-names>J</given-names></name><name><surname>O'Brien</surname><given-names>C</given-names></name><name><surname>Blaaow</surname><given-names>K</given-names></name><name><surname>Mercieca</surname><given-names>F</given-names></name><name><surname>Spiteri</surname><given-names>A</given-names></name><name><surname>Cobb</surname><given-names>CJ</given-names></name><name><surname>Damji</surname><given-names>KF</given-names></name><name><surname>Tarkkanen</surname><given-names>A</given-names></name><name><surname>Rezaie</surname><given-names>T</given-names></name><name><surname>Child</surname><given-names>AH</given-names></name><name><surname>Sarfarazi</surname><given-names>M</given-names></name></person-group><article-title>Evaluation of LOXL1 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>533</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">18385788</pub-id></citation></ref><ref id="r14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hewitt</surname><given-names>AW</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Burdon</surname><given-names>KP</given-names></name><name><surname>Wang</surname><given-names>JJ</given-names></name><name><surname>Baird</surname><given-names>PN</given-names></name><name><surname>Dimasi</surname><given-names>DP</given-names></name><name><surname>Mackey</surname><given-names>DA</given-names></name><name><surname>Mitchell</surname><given-names>P</given-names></name><name><surname>Craig</surname><given-names>JE</given-names></name></person-group><article-title>Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people.</article-title><source>Hum Mol Genet</source><year>2008</year><volume>17</volume><fpage>710</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">18037624</pub-id></citation></ref><ref id="r15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pasutto</surname><given-names>F</given-names></name><name><surname>Krumbiegel</surname><given-names>M</given-names></name><name><surname>Mardin</surname><given-names>CY</given-names></name><name><surname>Paoli</surname><given-names>D</given-names></name><name><surname>L&#x000e4;mmer</surname><given-names>R</given-names></name><name><surname>Weber</surname><given-names>BH</given-names></name><name><surname>Kruse</surname><given-names>FE</given-names></name><name><surname>Schl&#x000f6;tzer-Schrehardt</surname><given-names>U</given-names></name><name><surname>Reis</surname><given-names>A</given-names></name></person-group><article-title>Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2008</year><volume>49</volume><fpage>1459</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">18385063</pub-id></citation></ref><ref id="r16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mossb&#x000f6;ck</surname><given-names>G</given-names></name><name><surname>Renner</surname><given-names>W</given-names></name><name><surname>Faschinger</surname><given-names>C</given-names></name><name><surname>Schmut</surname><given-names>O</given-names></name><name><surname>Wedrich</surname><given-names>A</given-names></name><name><surname>Weger</surname><given-names>M</given-names></name></person-group><article-title>Lysyl oxidase-like protein 1 (LOXL1) gene polymorphisms and exfoliation glaucoma in a Central European population.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>857</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">18483563</pub-id></citation></ref><ref id="r17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramprasad</surname><given-names>VL</given-names></name><name><surname>George</surname><given-names>R</given-names></name><name><surname>Soumittra</surname><given-names>N</given-names></name><name><surname>Sharmila</surname><given-names>F</given-names></name><name><surname>Vijaya</surname><given-names>L</given-names></name><name><surname>Kumaramanickavel</surname><given-names>G</given-names></name></person-group><article-title>Association of non-synonymous single nucleotide polymorphisms in the LOXL1 gene with pseudoexfoliation syndrome in India.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>318</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">18334947</pub-id></citation></ref><ref id="r18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>H</given-names></name><name><surname>Gotoh</surname><given-names>N</given-names></name><name><surname>Ueda</surname><given-names>Y</given-names></name><name><surname>Nakanishi</surname><given-names>H</given-names></name><name><surname>Yoshimura</surname><given-names>N</given-names></name></person-group><article-title>Lysyl oxidase-like 1 polymorphisms and exfoliation syndrome in the Japanese population.</article-title><source>Am J Ophthalmol</source><year>2008</year><volume>145</volume><fpage>582</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">18201684</pub-id></citation></ref><ref id="r19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ozaki</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Vithana</surname><given-names>EN</given-names></name><name><surname>Yong</surname><given-names>VH</given-names></name><name><surname>Thalamuthu</surname><given-names>A</given-names></name><name><surname>Mizoguchi</surname><given-names>T</given-names></name><name><surname>Venkatraman</surname><given-names>A</given-names></name><name><surname>Aung</surname><given-names>T</given-names></name></person-group><article-title>Association of LOXL1 gene polymorphisms with pseudoexfoliation in the Japanese.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2008</year><volume>49</volume><fpage>3976</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">18450598</pub-id></citation></ref><ref id="r20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>K</given-names></name><name><surname>Imai</surname><given-names>K</given-names></name><name><surname>Matsuda</surname><given-names>A</given-names></name><name><surname>Ikeda</surname><given-names>Y</given-names></name><name><surname>Naruse</surname><given-names>S</given-names></name><name><surname>Hitora-Takeshita</surname><given-names>H</given-names></name><name><surname>Nakano</surname><given-names>M</given-names></name><name><surname>Taniguchi</surname><given-names>T</given-names></name><name><surname>Omi</surname><given-names>N</given-names></name><name><surname>Tashiro</surname><given-names>K</given-names></name><name><surname>Kinoshita</surname><given-names>S</given-names></name></person-group><article-title>LOXL1 genetic polymorphisms are associated with exfoliation glaucoma in the Japanese population.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>1037</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">18552979</pub-id></citation></ref><ref id="r21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mabuchi</surname><given-names>F</given-names></name><name><surname>Sakurada</surname><given-names>Y</given-names></name><name><surname>Kashiwagi</surname><given-names>K</given-names></name><name><surname>Yamagata</surname><given-names>Z</given-names></name><name><surname>Iijima</surname><given-names>H</given-names></name><name><surname>Tsukahara</surname><given-names>S</given-names></name></person-group><article-title>Lysyl oxidase-like 1 gene polymorphisms in Japanese patients with primary open angle glaucoma and exfoliation syndrome.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>1303</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18636115</pub-id></citation></ref><ref id="r22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fuse</surname><given-names>N</given-names></name><name><surname>Miyazawa</surname><given-names>A</given-names></name><name><surname>Nakazawa</surname><given-names>T</given-names></name><name><surname>Mengkegale</surname><given-names>M</given-names></name><name><surname>Otomo</surname><given-names>T</given-names></name><name><surname>Nishida</surname><given-names>K</given-names></name></person-group><article-title>Evaluation of LOXL1 polymorphisms in eyes with exfoliation glaucoma in Japanese.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>1338</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">18648524</pub-id></citation></ref><ref id="r23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wiggs</surname><given-names>JL</given-names></name></person-group><article-title>Association between LOXL1 and pseudoexfoliation.</article-title><source>Arch Ophthalmol</source><year>2008</year><volume>126</volume><fpage>420</fpage><lpage>1</lpage><pub-id pub-id-type="pmid">18332326</pub-id></citation></ref><ref id="r24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bleich</surname><given-names>S</given-names></name><name><surname>Roedl</surname><given-names>J</given-names></name><name><surname>Von Ahsen</surname><given-names>N</given-names></name><name><surname>Schl&#x000f6;tzer-Schrehardt</surname><given-names>U</given-names></name><name><surname>Reulbach</surname><given-names>U</given-names></name><name><surname>Beck</surname><given-names>G</given-names></name><name><surname>Kruse</surname><given-names>FE</given-names></name><name><surname>Naumann</surname><given-names>GO</given-names></name><name><surname>Kornhuber</surname><given-names>J</given-names></name><name><surname>J&#x000fc;nemann</surname><given-names>AG</given-names></name></person-group><article-title>Elevated homocysteine levels in aqueous humor of patients with pseudoexfoliation glaucoma.</article-title><source>Am J Ophthalmol</source><year>2004</year><volume>138</volume><fpage>162</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">15234308</pub-id></citation></ref><ref id="r25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roedl</surname><given-names>JB</given-names></name><name><surname>Bleich</surname><given-names>S</given-names></name><name><surname>Reulbach</surname><given-names>U</given-names></name><name><surname>Rejdak</surname><given-names>R</given-names></name><name><surname>Kornhuber</surname><given-names>J</given-names></name><name><surname>Kruse</surname><given-names>FE</given-names></name><name><surname>Schl&#x000f6;tzer-Schrehardt</surname><given-names>U</given-names></name><name><surname>J&#x000fc;nemann</surname><given-names>AG</given-names></name></person-group><article-title>Homocysteine in tear fluid of patients with pseudoexfoliation glaucoma.</article-title><source>J Glaucoma</source><year>2007</year><volume>16</volume><fpage>234</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17473737</pub-id></citation></ref><ref id="r26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Altintas</surname><given-names>O</given-names></name><name><surname>Maral</surname><given-names>H</given-names></name><name><surname>Yuksel</surname><given-names>N</given-names></name><name><surname>Karabas</surname><given-names>VL</given-names></name><name><surname>Dillioglugil</surname><given-names>MO</given-names></name><name><surname>Caglar</surname><given-names>Y</given-names></name></person-group><article-title>Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma.</article-title><source>Graefes Arch Clin Exp Ophthalmol</source><year>2005</year><volume>243</volume><fpage>677</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">15688159</pub-id></citation></ref><ref id="r27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schumacher</surname><given-names>S</given-names></name><name><surname>Schl&#x000f6;tzer-Schrehardt</surname><given-names>U</given-names></name><name><surname>Martus</surname><given-names>P</given-names></name><name><surname>Lang</surname><given-names>W</given-names></name><name><surname>Naumann</surname><given-names>GO</given-names></name></person-group><article-title>Pseudoexfoliation syndrome and aneurysms of the abdominal aorta.</article-title><source>Lancet</source><year>2001</year><volume>357</volume><fpage>359</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">11211000</pub-id></citation></ref><ref id="r28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wierzbicki</surname><given-names>AS</given-names></name></person-group><article-title>Homocysteine and cardiovascular disease: a review of the evidence.</article-title><source>Diab Vasc Dis Res</source><year>2007</year><volume>4</volume><fpage>143</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">17654449</pub-id></citation></ref><ref id="r29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>JC</given-names></name><name><surname>Fry</surname><given-names>B</given-names></name><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name></person-group><article-title>Haploview: analysis and visualization of LD and haplotype maps.</article-title><source>Bioinformatics</source><year>2005</year><volume>21</volume><fpage>263</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">15297300</pub-id></citation></ref><ref id="r30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Neale</surname><given-names>B</given-names></name><name><surname>Todd-Brown</surname><given-names>K</given-names></name><name><surname>Thomas</surname><given-names>L</given-names></name><name><surname>Ferreira</surname><given-names>MA</given-names></name><name><surname>Bender</surname><given-names>D</given-names></name><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>Sklar</surname><given-names>P</given-names></name><name><surname>de Bakker</surname><given-names>PI</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Sham</surname><given-names>PC</given-names></name></person-group><article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses.</article-title><source>Am J Hum Genet</source><year>2007</year><volume>81</volume><fpage>559</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">17701901</pub-id></citation></ref><ref id="r31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ott</surname><given-names>J</given-names></name><name><surname>Hoh</surname><given-names>J</given-names></name></person-group><article-title>Set association analysis of SNP case-control and microarray data.</article-title><source>J Comput Biol</source><year>2003</year><volume>10</volume><fpage>569</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">12935345</pub-id></citation></ref><ref id="r32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parodi</surname><given-names>MB</given-names></name><name><surname>Liberali</surname><given-names>T</given-names></name><name><surname>Iacono</surname><given-names>P</given-names></name><name><surname>De Nicola</surname><given-names>M</given-names></name><name><surname>Ballone</surname><given-names>E</given-names></name><name><surname>Ravalico</surname><given-names>G</given-names></name></person-group><article-title>The spectrum of iris angiography abnormalities in pseudoexfoliation syndrome.</article-title><source>Eye</source><year>2008</year><volume>22</volume><fpage>49</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">16980922</pub-id></citation></ref><ref id="r33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pascual</surname><given-names>G</given-names></name><name><surname>Mendieta</surname><given-names>C</given-names></name><name><surname>Mecham</surname><given-names>RP</given-names></name><name><surname>Sommer</surname><given-names>P</given-names></name><name><surname>Bell&#x000f3;n</surname><given-names>JM</given-names></name><name><surname>Buj&#x000e1;n</surname><given-names>J</given-names></name></person-group><article-title>Down-regulation of lysyl oxydase-like in aging and venous insufficiency.</article-title><source>Histol Histopathol</source><year>2008</year><volume>23</volume><fpage>179</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">17999374</pub-id></citation></ref><ref id="r34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>J&#x000fc;nemann</surname><given-names>AG</given-names></name><name><surname>von Ahsen</surname><given-names>N</given-names></name><name><surname>Reulbach</surname><given-names>U</given-names></name><name><surname>Roedl</surname><given-names>J</given-names></name><name><surname>B&#x000f6;nsch</surname><given-names>D</given-names></name><name><surname>Kornhuber</surname><given-names>J</given-names></name><name><surname>Kruse</surname><given-names>FE</given-names></name><name><surname>Bleich</surname><given-names>S</given-names></name></person-group><article-title>C677T variant in the methylentetrahydrofolate reductase gene is a genetic risk factor for primary open-angle glaucoma.</article-title><source>Am J Ophthalmol</source><year>2005</year><volume>139</volume><fpage>721</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">15808177</pub-id></citation></ref><ref id="r35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tura&#x000e7;li</surname><given-names>ME</given-names></name><name><surname>Tekeli</surname><given-names>O</given-names></name><name><surname>Ozdemir</surname><given-names>F</given-names></name><name><surname>Akar</surname><given-names>N</given-names></name></person-group><article-title>Methylenetetrahydrofolate reductase 677 C-T and homocysteine levels in Turkish patients with pseudoexfoliation.</article-title><source>Clin Experiment Ophthalmol</source><year>2005</year><volume>33</volume><fpage>505</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16181277</pub-id></citation></ref><ref id="r36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mossbock</surname><given-names>G</given-names></name><name><surname>Weger</surname><given-names>M</given-names></name><name><surname>Faschinger</surname><given-names>C</given-names></name><name><surname>Steinbrugger</surname><given-names>I</given-names></name><name><surname>Temmel</surname><given-names>W</given-names></name><name><surname>Schmut</surname><given-names>O</given-names></name><name><surname>Renner</surname><given-names>W</given-names></name><name><surname>Hufnagel</surname><given-names>C</given-names></name><name><surname>Stanger</surname><given-names>O</given-names></name></person-group><article-title>Methylenetetrahydrofolatereductase (MTHFR) 677C&#x0003e;T polymorphism and open angle glaucoma.</article-title><source>Mol Vis</source><year>2006</year><volume>12</volume><fpage>356</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16636653</pub-id></citation></ref><ref id="r37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fingert</surname><given-names>JH</given-names></name><name><surname>Kwon</surname><given-names>YH</given-names></name><name><surname>Moore</surname><given-names>PA</given-names></name><name><surname>Johnston</surname><given-names>RM</given-names></name><name><surname>Kim</surname><given-names>KY</given-names></name><name><surname>Sheffield</surname><given-names>VC</given-names></name><name><surname>Alward</surname><given-names>WL</given-names></name><name><surname>Stone</surname><given-names>EM</given-names></name></person-group><article-title>The C677T variant in the methylenetetrahydrofolate reductase gene is not associated with disease in cohorts of pseudoexfoliation glaucoma and primary open-angle glaucoma patients from Iowa.</article-title><source>Ophthalmic Genet</source><year>2006</year><volume>27</volume><fpage>39</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">16754204</pub-id></citation></ref><ref id="r38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mabuchi</surname><given-names>F</given-names></name><name><surname>Tang</surname><given-names>S</given-names></name><name><surname>Kashiwagi</surname><given-names>K</given-names></name><name><surname>Yamagata</surname><given-names>Z</given-names></name><name><surname>Iijima</surname><given-names>H</given-names></name><name><surname>Tsukahara</surname><given-names>S</given-names></name></person-group><article-title>Methylenetetrahydrofolate reductase gene polymorphisms c.677C/T and c.1298A/C are not associated with open angle glaucoma.</article-title><source>Mol Vis</source><year>2006</year><volume>12</volume><fpage>735</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16862068</pub-id></citation></ref><ref id="r39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zetterberg</surname><given-names>M</given-names></name><name><surname>Tasa</surname><given-names>G</given-names></name><name><surname>Palm&#x000e9;r</surname><given-names>MS</given-names></name><name><surname>Juronen</surname><given-names>E</given-names></name><name><surname>Toover</surname><given-names>E</given-names></name><name><surname>Blennow</surname><given-names>K</given-names></name><name><surname>Zetterberg</surname><given-names>H</given-names></name></person-group><article-title>Methylenetetrahydrofolate reductase genetic polymorphisms in patients with primary open-angle glaucoma.</article-title><source>Ophthalmic Genet</source><year>2007</year><volume>28</volume><fpage>47</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">17558844</pub-id></citation></ref><ref id="r40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>MY</given-names></name><name><surname>Bignell</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Welge</surname><given-names>BG</given-names></name><name><surname>Graham</surname><given-names>KJ</given-names></name><name><surname>Hanson</surname><given-names>NQ</given-names></name></person-group><article-title>Polygenic influence on plasma homocysteine: association of two prevalent mutations, the 844ins68 of cystathionine beta-synthase and A(2756)G of methionine synthase, with lowered plasma homocysteine levels.</article-title><source>Atherosclerosis</source><year>2000</year><volume>149</volume><fpage>131</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">10704624</pub-id></citation></ref><ref id="r41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fredriksen</surname><given-names>A</given-names></name><name><surname>Meyer</surname><given-names>K</given-names></name><name><surname>Ueland</surname><given-names>PM</given-names></name><name><surname>Vollset</surname><given-names>SE</given-names></name><name><surname>Grotmol</surname><given-names>T</given-names></name><name><surname>Schneede</surname><given-names>J</given-names></name></person-group><article-title>Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism.</article-title><source>Hum Mutat</source><year>2007</year><volume>28</volume><fpage>856</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">17436311</pub-id></citation></ref><ref id="r42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Dai</surname><given-names>C</given-names></name></person-group><article-title>Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases.</article-title><source>Thromb Res</source><year>2001</year><volume>104</volume><fpage>187</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">11672761</pub-id></citation></ref><ref id="r43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Cherny</surname><given-names>SS</given-names></name><name><surname>Sham</surname><given-names>PC</given-names></name></person-group><article-title>Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits.</article-title><source>Bioinformatics</source><year>2003</year><volume>19</volume><fpage>149</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">12499305</pub-id></citation></ref><ref id="r44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roedl</surname><given-names>JB</given-names></name><name><surname>Bleich</surname><given-names>S</given-names></name><name><surname>Reulbach</surname><given-names>U</given-names></name><name><surname>Rejdak</surname><given-names>R</given-names></name><name><surname>Naumann</surname><given-names>GO</given-names></name><name><surname>Kruse</surname><given-names>FE</given-names></name><name><surname>Schl&#x000f6;tzer-Schrehardt</surname><given-names>U</given-names></name><name><surname>Kornhuber</surname><given-names>J</given-names></name><name><surname>J&#x000fc;nemann</surname><given-names>AG</given-names></name></person-group><article-title>Vitamin deficiency and hyperhomocysteinemia in pseudoexfoliation glaucoma.</article-title><source>J Neural Transm</source><year>2007</year><volume>114</volume><fpage>571</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">17238009</pub-id></citation></ref></ref-list></back></article> 